Exane Derivatives’s Ashland ASH Stock Holding History

Exane Derivatives’s Portfolio ASH Stock Details ASH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-222,183	Closed	-$13M	–	518
2014 Q4	$13M	Buy	+222,183	New	+$12M	1.8%	17

Other funds holding ASH

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

ETC

Evercore Trust Company New York $34.6B AUM 25.41% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Exane Derivatives's ASH Position: Q1 2015 in Review

Exane Derivatives sold out of Ashland (ASH) in Q1 2015, closing a stake of 222,183 shares — an estimated $13M sold.

Exane Derivatives first reported a position in ASH in Q4 2014 and held it in 1 quarter. The position peaked at $13M in Q4 2014. 384 funds tracked by Wall St. Rank hold ASH as of Q1 2015.

Exane Derivatives reported no remaining Ashland position as of Q1 2015 after selling out during the quarter.
Exane Derivatives sold 222,183 Ashland shares in Q1 2015, an estimated $13M.
Exane Derivatives first reported a position in Ashland in Q4 2014 and held it in 1 quarter.
Exane Derivatives's Ashland position peaked at $13M in Q4 2014.
384 funds tracked by Wall St. Rank held Ashland as of Q1 2015.

Based on Exane Derivatives's 13F filing for Q1 2015, filed 15 May 2015.